Abstract
Introduction: With increasing knowledge about limitations of systemic steroids, the use of steroid sparing agents is now being accepted by practicing dermatologists. Methotrexate (MTX) is a well accepted steroid sparing drug in adults with dermatological conditions. However, its use in pediatric dermatoses has not been the subject of many investigations. Materials and Methods: We decided to do a computerized search for the use of MTX in pediatric dermatoses using terms like pediatric,'' MTX, psoriasis,'' pityriasis rubra pilaris (PRP), atopic dermatitis, pityriasis lichenoides, lichen planus, juvenile dermatomyositis (JDMS), localized morphea, systemic lupus erythematosus (SLE), vesiculo-bullous diseases, alopecia areata, vasculitis, eosinophilic fasciitis, urticaria, sarcoidosis, pompholyx and vitiligo vulgaris. All the articles were retrieved and classified into review articles, studies, double-blinded trials and case reports. The final data were then analyzed. Results: It has been found that MTX has been increasingly used in psoriasis, PRP, pityriasis lichenoides, JDMS, SLE and sarcoidosis. However, its use in several other dermatoses is restricted to isolated case reports. Conclusion: Children tolerate MTX better than adults. However, proper clinical and laboratory surveillance has to be maintained in patients on long term MTX.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
